Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls

Clinical and Experimental Medicine

Volumn 12, Issue 3, 2012, Pages 181-194

  Mazzoccoli, Gianluigi ^a   Sothern, Robert B ^b   Parrella, Paola ^a   Muscarella, Lucia A ^a   Fazio, Vito Michele ^a   Giuliani, Francesco ^a   Polyakova, Victoria ^c,d   Kvetnoy, Igor M ^c,d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF MINNESOTA   (United States)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^d D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

Author keywords

Circadian rhythmicity; Cortisol; IL2; Lymphocyte subpopulations; Melatonin; NSCLC

Indexed keywords

CD16 ANTIGEN; CD8 ANTIGEN; HYDROCORTISONE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MELATONIN;

ADULT; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; HISTOGENESIS; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE METABOLISM;

ADULT; ANALYSIS OF VARIANCE; B-LYMPHOCYTE SUBSETS; BODY MASS INDEX; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; HUMANS; HYDROCORTISONE; INTERLEUKIN-2; KILLER CELLS, NATURAL; LINEAR MODELS; LYMPHOCYTE COUNT; MALE; MELATONIN; MIDDLE AGED; NEOPLASM METASTASIS; T-LYMPHOCYTE SUBSETS;

EID: 84865457994     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0153-6     Document Type: Article

References (70)

1. KE de Visser A Eichten LM Coussens 2006 Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 1 24 37 16397525 10.1038/nrc1782
2. T Zhang D Herlyn 2009 Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer Cancer Immunol Immunother 58 4 475 492 18925393 10.1007/s00262-008- 0598-y 1:CAS:528:DC%2BD1MXht1Olsbs%3D
3. C Blank A Mackensen 2007 Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion Cancer Immunol Immunother 56 5 739 745 17195077 10.1007/s00262-006-0272-1
4. X Zang JP Allison 2007 The B7 family and cancer therapy: costimulation and coinhibition Cancer Res 13 18 Pt 1 5271 5279 1:CAS:528:DC%2BD2sXhtVCitL7L
5. BA Inman X Frigola H Dong ED Kwon 2007 Costimulation, coinhibition and cancer Curr Cancer Drug Targets 7 1 15 30 17305475 10.2174/156800907780006878 1:CAS:528:DC%2BD2sXitVOgsbc%3D Review
6. CH June BR Blazar JL Riley 2009 Engineering lymphocyte subsets: tools, trials and tribulations Nat Rev Immunol 9 10 704 716 19859065 10.1038/nri2635 1:CAS:528:DC%2BD1MXhtFOhs77K
7. S Motohashi T Nakayama 2008 Clinical applications of natural killer T cell-based immunotherapy for cancer Cancer Sci 99 4 638 645 18294290 10.1111/j.1349-7006.2008.00730.x 1:CAS:528:DC%2BD1cXls1Sksrs%3D
8. YL Zhang J Li HY Mo, et al. 2010 Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways Mol Cancer 10 9 4 10.1186/1476-4598-9-4
9. B Savas PE Kerr HF Pross 2006 Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma Cancer Cell Int 6 24 37 17081316 10.1186/1475-2867-6-24
10. D Kabelitz D Wesch W He 2007 Perspectives of gammadelta T cells in tumor immunology Cancer Res 67 1 5 8 17210676 10.1158/0008-5472.CAN-06-3069 1:CAS:528:DC%2BD2sXisFWhsg%3D%3D
11. A Mantovani B Bottazzi F Colotta S Sozzani L Ruco 1992 The origin and function of tumor-associated macrophages Immunol Today 13 7 265 270 1388654 10.1016/0167-5699(92)90008-U 1:CAS:528:DyaK38XlsVyltrY%3D
12. P Allavena A Sica G Solinas C Porta A Mantovani 2008 The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages Oncol Hematol 66 1 1 9
13. HH van Ravenswaay Claasen PM Kluin GJ Fleuren 1992 Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity Lab Invest 67 2 166 174 1501443
14. Sothern RB (2006) Clinical medicine. In: Koukkari WL, Sothern RB (eds) Introducing biological rhythms. Springer, New York, pp 426-525
15. E Haus 2007 Chronobiology in the endocrine system Adv Drug Deliv Rev 59 9-10 985 1014 17804113 10.1016/j.addr.2007.01.001 1:CAS:528:DC%2BD2sXhtFGrtbzP
16. I Edery 2000 Circadian rhythms in a nutshell Physiol Genomics 3 2 59 74 11015601 1:STN:280:DC%2BD3cvmslenug%3D%3D
17. MH Hastings AB Reddy ES Maywood 2003 A clockwork web: circadian timing in brain and periphery, in health and disease Nat Rev Neurosci 4 649 661 12894240 10.1038/nrn1177 1:CAS:528:DC%2BD3sXlvV2itbw%3D
18. F Gachon E Nagoshi SA Brown J Ripperger U Schibler 2004 The mammalian circadian timing system: from gene expression to physiology Chromosoma 113 103 112 15338234 10.1007/s00412-004-0296-2
19. CH Ko JS Takahashi 2006 Molecular components of the mammalian circadian clock Hum Mol Genet 15 R271 R277 16987893 10.1093/hmg/ddl207 1:CAS:528:DC%2BD28XpvFGlsLg%3D Review
20. F Damiola N Le Minh N Preitner B Kornmann F Fleury-Olela U Schibler 2000 Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus Genes Dev 14 2950 2961 11114885 10.1101/gad.183500 1:CAS:528:DC%2BD3cXptVWltrs%3D
21. KA Stokkan S Yamazaki H Tei Y Sakaki M Menaker 2001 Entrainment of the circadian clock in the liver by feeding Science 291 490 493 11161204 10.1126/science.291.5503.490 1:CAS:528:DC%2BD3MXlslensQ%3D%3D
22. L Fu CC Lee 2004 The circadian clock: pacemaker and tumour suppressor Nature Rev Cancer 3 350 361 10.1038/nrc1072
23. E Nagoshi C Saini C Bauer T Laroche F Naef U Schibler 2004 Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells Cell 119 693 705 15550250 10.1016/j.cell.2004.11.015 1:CAS:528:DC%2BD2cXhtVGls7fL
24. G Mazzoccoli M Correra G Bianco, et al. 1997 Age-related changes of neuro-endocrine-immune interactions in healthy humans J Biol Reg Hom Agents 11 4 143 147 1:CAS:528:DyaK1cXivVKls78%3D
25. S Suzuki S Toyabe T Moroda 1997 Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system Clin Exp Immunol 110 3 500 508 9409657 10.1046/j.1365-2249.1997.4411460.x 1:STN:280:DyaK1c%2Fnt1eitw%3D%3D
26. Mazzoccoli G, Sothern RB, De Cata A et al (2011) A timetable of 24-hour patterns for human lymphocyte subpopulations. J Biol Regul Homeost Agents (in press)
27. KS Blum R Pabst 2007 Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol Lett 108 1 45 51 17129612 10.1016/j.imlet.2006.10.009 1:CAS:528:DC%2BD2sXht1Sjtw%3D%3D
28. S Dimitrov C Benedict D Heutling J Westermann J Born T Lange 2009 Cortisol and epinephrine control opposing circadian rhythms in T cell subsets Blood 113 21 5134 5143 19293427 10.1182/blood-2008-11-190769 1:CAS:528:DC%2BD1MXmslalur8%3D
29. S Dimitrov T Lange J Born 2010 Selective mobilization of cytotoxic leukocytes by epinephrine J Immunol 184 1 503 511 19949113 10.4049/jimmunol. 0902189 1:CAS:528:DC%2BD1MXhsFOnsLfJ
30. G Mazzoccoli A De Cata A Greco S Carughi F Giuliani R Tarquini 2010 Circadian rhythmicity of lymphocyte subpopulations and relationship with neuro-endocrine system J Biol Reg Homest Agents 24 3 341 350 1:STN:280:DC%2BC3cfjtVSgsw%3D%3D
31. M Teboul M-A Barrat-Petit X Mei Li B Claustrat J-L Formento F Delaunay 2005 Atypical patterns of circadian clock gene expression in human peripheral blood mononuclear cells J Mol Med 83 9 693 699 16096739 10.1007/s00109-005-0697- 6 1:CAS:528:DC%2BD2MXpsFWiu74%3D
32. H Fukuya N Emoto H Nonaka K Yagita H Okamura M Yokoyama 2007 Circadian expression of clock genes in human peripheral leukocytes Biochem Biophys Res Commun 354 4 924 928 17274950 10.1016/j.bbrc.2007.01.063 1:CAS:528: DC%2BD2sXhs1SntrY%3D
33. L Borgs P Beukelaers R Vandenbosch S Belachew L Nguyen B Malgrange 2009 Cell "circadian" cycle: new role for mammalian core clock genes Cell Cycle 8 6 832 837 19221497 10.4161/cc.8.6.7869 1:CAS:528:DC%2BD1MXlvFWis7s%3D
34. A Estrela-Lima MS Araújo JM Costa-Neto, et al. 2010 Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates BMC Cancer 10 256 20525350 10.1186/1471-2407-10-256
35. G Mazzoccoli M Grilli S Carughi, et al. 2003 Immune system alterations in lung cancer patients Int J Immunopathol Pharmacol 16 2 167 174 12797908 1:CAS:528:DC%2BD3sXmvF2ks7s%3D
36. P Sharma 2009 Preanalytical variables and laboratory performance Ind J Clin Biochem 24 109 110 10.1007/s12291-009-0021-2
37. W Göhde U Cassens LG Lehman, et al. 2003 Individual patient-dependent influence of erythrocyte lysing procedures on flow-cytometric analysis of leukocyte subpopulations Transfus Med Hemother 30 165 170 10.1159/000073325
38. EB Klerman HB Gershengorn JF Duffy RE Kronauer 2002 Comparisons of the variability of three markers of the human circadian pacemaker J Biol Rhythms 17 2 181 193 12002165 10.1177/074873002129002474 1:CAS:528:DC%2BD38XjsVCksro%3D
39. W Nelson YL Tong YK Lee F Halberg 1979 Methods for cosinor rhythmometry Chronobiologia 6 4 305 323 548245 1:STN:280:DyaL3c3isVWntQ%3D%3D
40. A Mojón JR Fernández R Hermida 1992 Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer Chronobiol Intl 9 6 403 412 10.3109/07420529209064552
41. G Parmiani 2005 Tumor-infiltrating T cells-friend or foe of neoplastic cells? N Engl J Med 353 25 2640 2641 16371629 10.1056/NEJMp058236
42. G Bindea B Mlecnik WH Fridman F Pagès J Galon 2010 Natural immunity to cancer in humans Curr Opin Immunol 22 2 215 222 20207124 10.1016/j.coi.2010.02.006 1:CAS:528:DC%2BC3cXks1Srsbk%3D
43. A Mantovani 2010 Molecular pathways linking inflammation and cancer Curr Mol Med 10 4 369 373 20455855 10.2174/156652410791316968 1:CAS:528: DC%2BC3cXmsVamsb4%3D Review
44. DS O'Callaghan D O'Donnell F O'Connell KJ O'Byrne 2010 The role of inflammation in the pathogenesis of non-small cell lung cancer J Thorac Oncol 5 12 2024 2036 21155185 10.1097/JTO.0b013e3181f387e4 Review
45. P Allavena G Germano F Marchesi A Mantovani 2011 Chemokines in cancer related inflammation Exp Cell Res 317 5 664 673 21134366 10.1016/j.yexcr.2010. 11.013 1:CAS:528:DC%2BC3MXjsFaitrw%3D Review
46. RH Thompson H Dong ED Kwon 2007 Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy Clin Cancer Res 13 2 Pt 2 709s 715s 17255298 10.1158/1078-0432.CCR-06-1868 1:CAS:528: DC%2BD2sXoslSqsw%3D%3D
47. H Ghebeh E Barhoush A Tulbah N Elkum T Al-Tweigeri S Dermime 2008 FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: implication for immunotherapy BMC Cancer 23 8 57 10.1186/1471-2407-8-57
48. G Mazzoccoli G Vendemiale A De Cata S Carughi R Tarquini 2010 Altered time structure of neuro-endocrine-immune system function in lung cancer patients BMC Cancer 10 1 314 20565977 10.1186/1471-2407-10-314
49. MT Hueman A Stojadinovic CE Storrer, et al. 2007 Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine Cancer Immunol Immunother 56 2 135 146 16783576 10.1007/s00262-006-0188-9 1:CAS:528:DC%2BD28Xht1Gnu7vF
50. T Eckschlager J Radvanska K Slaby R Prusa I Hochova J Radvansky 2009 Changes of blood count, lymphocyte subpopulations and immunoglobulin levels in nephroblastoma long term survivors Neoplasma 56 1 9 12 19152239 10.4149/neo-2009-01-9 1:STN:280:DC%2BD1M%2FotFKguw%3D%3D
51. LA Ormandy T Hillemann H Wedemeyer MP Manns TF Greten F Korangy 2005 Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 6 2457 2464 15781662 10.1158/0008-5472.CAN-04-3232 1:CAS:528:DC%2BD2MXisFGnsL0%3D
52. GC Cesana G DeRaffele S Cohen, et al. 2006 Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma J Clin Oncol 24 7 1169 1177 16505437 10.1200/JCO.2005.03.6830 1:CAS:528:DC%2BD28XislGgsbc%3D
53. M Beyer M Kochanek K Darabi, et al. 2005 Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine Blood 106 6 2018 2025 15914560 10.1182/blood-2005-02-0642 1:CAS:528:DC%2BD2MXhtVWksLrM
54. EY Woo CS Chu TJ Goletz, et al. 2001 Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Res 61 12 4766 4772 11406550 1:CAS:528: DC%2BD3MXks1GrtbY%3D
55. F Meloni M Morosini N Solari, et al. 2006 Foxp3 expressing CD4+CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma Hum Immunol 67 1-2 1 12 16698419 10.1016/j.humimm.2005.11.005 1:CAS:528:DC%2BD28Xks1elsbg%3D
56. BH Nelson 2008 The impact of T-cell immunity on ovarian cancer outcomes Immunol Rev 222 101 116 18363996 10.1111/j.1600-065X.2008.00614.x 1:CAS:528:DC%2BD1cXlsFejtrs%3D Review
57. K Ebelt G Babaryka B Frankenberger, et al. 2009 Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters Eur J Cancer 45 9 1664 1672 19318244 10.1016/j.ejca.2009.02.015 1:CAS:528:DC%2BD1MXms1WmtLk%3D
58. P Salama M Phillips F Grieu, et al. 2009 Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer J Clin Oncol 27 2 186 192 19064967 10.1200/JCO.2008.18.7229
59. B Karagöz O Bilgi M Gümüs, et al. 2010 CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients Med Oncol 27 1 29 33 19148592 10.1007/s12032-008-9165-9
60. N Chaput S Louafi A Bardier, et al. 2009 Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue Gut 58 4 520 529 19022917 10.1136/gut.2008.158824 1:CAS:528:DC%2BC3cXivFWlsbw%3D
61. LS Shen J Wang DF Shen, et al. 2009 CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression Clin Immunol 131 1 109 118 19153062 10.1016/j.clim.2008.11.010 1:CAS:528:DC%2BD1MXktFWktbs%3D
62. VM Cassone AK Natesan 1997 Time and time again: the phylogeny of melatonin as a transducer of biological time J Biol Rhythms 12 489 497 9406022 10.1177/074873049701200602 1:CAS:528:DyaK1cXhsF2ltLY%3D Review
63. RJ Reiter 1991 Pineal melatonin: cell biology of its synthesis and its physiological interactions Endocr Rev 12 151 179 1649044 10.1210/edrv-12-2-151 1:CAS:528:DyaK3MXlsFSlsLs%3D
64. RJ Reiter DX Tan L Fuentes-Broto 2010 Melatonin: a multitasking molecule Prog Brain Res 181 127 151 20478436 10.1016/S0079-6123(08)81008-4 1:CAS:528:DC%2BC3cXhtVajtb7J Review
65. E Van Cauter 1990 Diurnal and ultradian rhythms in human endocrine function: a minireview Horm Res 34 45 53 1965834 10.1159/000181794
66. JA Gusenoff S Harman JD Veldhuis, et al. 2001 Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men Am J Physiol Endocrinol Metab 280 E616 E625 11254469 1:CAS:528:DC%2BD3MXjtVyqsL0%3D
67. E Haus 2007 Chronobiology in the endocrine system Adv Drug Deliv Rev 59 985 1014 17804113 10.1016/j.addr.2007.01.001 1:CAS:528:DC%2BD2sXhtFGrtbzP
68. F Lévi A Okyar S Dulong PF Innominato J Clairambault 2010 Circadian timing in cancer treatments Annu Rev Pharmacol Toxicol 50 377 421 20055686 10.1146/annurev.pharmtox.48.113006.094626 Review
69. S Ohdo 2010 Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption Adv Drug Deliv Rev 62 9-10 859 875 20188774 10.1016/j.addr.2010. 01.006 1:CAS:528:DC%2BC3cXhtVaqsLnJ Review
70. Mazzoccoli G, Giuliani F, Sothern RB (2011) Whole body circadian phase evaluated from melatonin and cortisol sampled every 4 h over 24 h in healthy men. Cancer Epidemiol (in press)